These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Topoisomerase I peptide-loaded dendritic cells induce autoantibody response as well as skin and lung fibrosis. Mehta H; Goulet PO; Nguyen V; Pérez G; Koenig M; Senécal JL; Sarfati M Autoimmunity; 2016 Dec; 49(8):503-513. PubMed ID: 27808577 [TBL] [Abstract][Full Text] [Related]
3. Early-Life Antibiotic Exposure Causes Intestinal Dysbiosis and Exacerbates Skin and Lung Pathology in Experimental Systemic Sclerosis. Mehta H; Goulet PO; Mashiko S; Desjardins J; Pérez G; Koenig M; Senécal JL; Constante M; Santos MM; Sarfati M J Invest Dermatol; 2017 Nov; 137(11):2316-2325. PubMed ID: 28757138 [TBL] [Abstract][Full Text] [Related]
4. Immunization with DNA topoisomerase I and Freund's complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling. Yoshizaki A; Yanaba K; Ogawa A; Asano Y; Kadono T; Sato S Arthritis Rheum; 2011 Nov; 63(11):3575-85. PubMed ID: 21792823 [TBL] [Abstract][Full Text] [Related]
6. Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade. Marut W; Kavian N; Servettaz A; Hua-Huy T; Nicco C; Chéreau C; Weill B; Dinh-Xuan AT; Batteux F Arthritis Rheum; 2013 May; 65(5):1367-77. PubMed ID: 23335130 [TBL] [Abstract][Full Text] [Related]
7. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis. Kim D; Peck A; Santer D; Patole P; Schwartz SM; Molitor JA; Arnett FC; Elkon KB Arthritis Rheum; 2008 Jul; 58(7):2163-73. PubMed ID: 18576347 [TBL] [Abstract][Full Text] [Related]
8. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis. Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329 [TBL] [Abstract][Full Text] [Related]
9. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756 [TBL] [Abstract][Full Text] [Related]
10. Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis. Stenström M; Nyhlén HC; Törngren M; Liberg D; Sparre B; Tuvesson H; Eriksson H; Leanderson T J Dermatol Sci; 2016 Jul; 83(1):52-9. PubMed ID: 27156795 [TBL] [Abstract][Full Text] [Related]
11. The organotelluride catalyst (PHTE)₂NQ prevents HOCl-induced systemic sclerosis in mouse. Marut WK; Kavian N; Servettaz A; Nicco C; Ba LA; Doering M; Chéreau C; Jacob C; Weill B; Batteux F J Invest Dermatol; 2012 Apr; 132(4):1125-32. PubMed ID: 22277946 [TBL] [Abstract][Full Text] [Related]
12. The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis. Manetti M; Ibba-Manneschi L; Liakouli V; Guiducci S; Milia AF; Benelli G; Marrelli A; Conforti ML; Romano E; Giacomelli R; Matucci-Cerinic M; Cipriani P Ann Rheum Dis; 2010 Mar; 69(3):598-605. PubMed ID: 19778913 [TBL] [Abstract][Full Text] [Related]
13. The specific free radical scavenger edaravone suppresses fibrosis in the bleomycin-induced and tight skin mouse models of systemic sclerosis. Yoshizaki A; Yanaba K; Ogawa A; Iwata Y; Ogawa F; Takenaka M; Shimizu K; Asano Y; Kadono T; Sato S Arthritis Rheum; 2011 Oct; 63(10):3086-97. PubMed ID: 21618208 [TBL] [Abstract][Full Text] [Related]
15. Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody. Komura K; Yanaba K; Ogawa F; Shimizu K; Takehara K; Sato S Clin Exp Dermatol; 2008 May; 33(3):329-32. PubMed ID: 18312458 [TBL] [Abstract][Full Text] [Related]
16. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis. Yoshizaki A; Yanaba K; Yoshizaki A; Iwata Y; Komura K; Ogawa F; Takenaka M; Shimizu K; Asano Y; Hasegawa M; Fujimoto M; Sato S Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis. Maurer B; Distler A; Suliman YA; Gay RE; Michel BA; Gay S; Distler JH; Distler O Ann Rheum Dis; 2014 Oct; 73(10):1880-7. PubMed ID: 23918036 [TBL] [Abstract][Full Text] [Related]
18. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis. Wohlfahrt T; Usherenko S; Englbrecht M; Dees C; Weber S; Beyer C; Gelse K; Distler O; Schett G; Distler JH; Ramming A Ann Rheum Dis; 2016 Mar; 75(3):623-6. PubMed ID: 26338035 [TBL] [Abstract][Full Text] [Related]
19. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma? Manetti M; Rosa I; Milia AF; Guiducci S; Carmeliet P; Ibba-Manneschi L; Matucci-Cerinic M Ann Rheum Dis; 2014 Sep; 73(9):1700-9. PubMed ID: 23852693 [TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of Th17 cells and related cytokines in a murine model of systemic sclerosis]. Lei L; Zhong XN; Zhao C; Mi CD; Li JQ; Zeng JJ Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):259-64. PubMed ID: 22517000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]